Delivery Order SPE2DR25D3504-SPE2DR26F7BB9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL with a ceiling value of $3,476.25. The contract is a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls with a ceiling value of $1,648.66. This delivery order, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, utilizes firm fixed-price pricing with no set-aside designation. The award represents a competitive procurement for this pharmaceutical product, which will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,441.44 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $41,849.48 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40mg/4ml (2-pack units) on November 18, 2025, with a completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $36,425.77 delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40mg/4ml (2 units) under a firm fixed price contract. This delivery order, issued on October 27, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been selected to fulfill this medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,321.40 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat various inflammatory conditions. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL with a ceiling value of $7,485.34. This is a firm fixed-price, non-set-aside competitive award issued on October 17, 2025, with an ultimate completion date of October 20, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order is...
- The Defense Logistics Agency awarded a $37,990.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract, executed on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a non-competitive award under an existing indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,387.94 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award selection. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a prescription medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $13,730.83, is scheduled for completion by November 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BB9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL with a ceiling value of $1,322.82. The contract, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The delivery order for HUMIRA, an immunosuppressant medication, fulfills federal medical procurement needs for military and veteran healthcare systems under this framework agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/18/25 |